Cardiology

AHA: Inclisiran twice yearly may effectively control cholesterol

(HealthDay)—A new injectable medication called inclisiran cuts low-density lipoprotein (LDL) cholesterol by half or more, and the effect could last for four to six months, according to research presented at the annual meeting ...

Cardiology

PCSK9 inhibitors reduce lipoprotein (a) production

A new study published today in JACC: Basic to Translational Science sheds light on PCSK9 inhibitors, a new class of low density lipoprotein (LDL) lowering drugs, and their impact on another risk factor for heart disease, ...

Health

Air pollution exposure may raise heart disease risk

Exposure to air pollution can worsen blood sugar levels, cholesterol and other risk factors for heart disease, particularly in people with diabetes, according to a new study published in the Endocrine Society's Journal of ...

Oncology & Cancer

Cholesterol levels, not statins, influence colorectal cancer risk

Long-term use of the cholesterol-lowering drugs known as statins does not appear to decrease a patient's risk of colorectal cancer, suggests a new, large case-control study from Penn Medicine researchers published this week ...

page 19 from 38